All Stories

  1. Effect of a Constant Magnetic Field on Cell Morphology and Migration Mediated by Cytoskeleton-Bound Magnetic Nanoparticles
  2. Synthesis of Conjugates of PEG-RGD Derivatives with Fe3O4 Magnetic Nanoparticles for Cell Labelling
  3. Immobilization of doxorubicin on Fe3O4 magnetic nanoparticles modified with iron and silicon glycerolates
  4. Nano-bio interaction of magnetic nanoparticles with cells in a tumor at the single-cell level
  5. Effect of a constant magnetic field on morphology and motility of cell with cytoskeleton-associated magnetic nanoparticles
  6. Synthesis of closo- and nido-carborane derivatives of the KRGD peptide
  7. Nanocomposite material based on Fe3O4 magnetic nanoparticles modified with iron and silicon glycerolates: synthesis and characterization
  8. Magnetic Nanocomposite Materials Based on Fe3O4 Nanoparticles with Iron and Silica Glycerolates Shell: Synthesis and Characterization
  9. Synthesis of Novel Carborane-Containing Derivatives of RGD Peptide
  10. Features of doxorubicin adsorption on Fe3O4 magnetic nanoparticles coated with SiO2 or SiO2/aminopropylsilane
  11. Removal of microplastics from water by using magnetic sedimentation
  12. Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles
  13. Effect of the Silica–Magnetite Nanocomposite Coating Functionalization on the Doxorubicin Sorption/Desorption
  14. Magnetic-Responsive Doxorubicin-Containing Materials Based on Fe3O4 Nanoparticles with a SiO2/PEG Shell and Study of Their Effects on Cancer Cell Lines
  15. Comparative study of L-Lys modification of gas-condensation and chemically obtained magnetic Fe3O4 nanoparticles for cell labelling
  16. Synthesis of fluorescent GRGD peptide derivatives
  17. Individual iron(iii) glycerolate: synthesis and characterisation
  18. Smart Design of a pH-Responsive System Based on pHLIP-Modified Magnetite Nanoparticles for Tumor MRI
  19. Modification of chemically and physically obtained Fe3O4 magnetic nanoparticles with l-Lys for cell labeling
  20. Design of SiO2/aminopropylsilane-modified magnetic Fe3O4 nanoparticles for doxorubicin immobilization
  21. Silica coating of Fe3O4 magnetic nanoparticles with PMIDA assistance to increase the surface area and enhance peptide immobilization efficiency
  22. Synthesis of Fe@C nanoparticles containing sulfo groups on their surfaces and study of their aggregation behavior in aqueous media
  23. Modification of Fe3O4 magnetic nanoparticles with a GRGD peptide
  24. Variation in tumor pH affects pH-triggered delivery of peptide-modified magnetic nanoparticles
  25. Modification of human monocytes and macrophages by magnetic nanoparticles in vitro for cell-based delivery
  26. L-Lysine-modified Fe3O4 nanoparticles for magnetic cell labeling
  27. pH-triggered delivery of magnetic nanoparticles depends on tumor volume
  28. Factors Affecting the Labeling of NIH 3T3 Cells with Magnetic Nanoparticles
  29. Supporting data and methods for the characterization of iron oxide nanoparticles conjugated with pH-(low)-insertion peptide, testing their cytotoxicity and analyses of biodistribution in SCID mice bearing MDA-MB231 tumor
  30. NMR Relaxometry at Quantification of the Captured Magnetic Nanoparticles by Cells
  31. Synthesis of glutaryl-containing derivatives of GRGD and KRGD peptides
  32. Immobilization of a pH-low insertion peptide onto SiO2/aminosilane-coated magnetite nanoparticles
  33. Synthesis and Quantification of 2-(Diethylamino)-N-(2-methylphenyl)acetamide Nitrate
  34. Synthesis of nanocomposite with a core—shell structure based on Fe3O4 magnetic nanoparticles and iron glycerolate
  35. Immobilization of fluorescent protein TagGFP2 on Fe3O4-based magnetic nanoparticles
  36. Magnetic Properties and Structure of TiO2-Mn (0.73%) Nanopowders: the Effects of Electron Irradiation and Vacuum Annealing
  37. Modifying the surface of cerium oxide nanopowders produced by physical method
  38. Immobilization of PMIDA on Fe 3 O 4 magnetic nanoparticles surface: Mechanism of bonding
  39. PMIDA-Modified Fe3O4 Magnetic Nanoparticles: Synthesis and Application for Liver MRI
  40. Murine and human hematopoietic progenitor cultures grown on stromal layers expressing Notch ligands
  41. MNPs for contrast-enhanced MRI
  42. Magnetic stromal layers for enhanced and unbiased recovery of co-cultured hematopoietic cells
  43. Synthesis of hybrid nanoparticles based on magnetic Fe3O4 nanoparticles and luminescent CdS nanoparticles
  44. The design of hybrid materials based on magnetic Fe3O4 nanoparticles and luminescent CdS nanoparticles for cell visualization
  45. pHLIP-modified magnetic nanoparticles for targeting acidic diseased tissue
  46. Correction: pHLIP-modified magnetic nanoparticles for targeting acidic diseased tissue
  47. Hemozoin “knobs” in Opisthorchis felineus infected liver
  48. Synthesis of enantiomers of N-(2-aminopurin-6-yl)amino acids
  49. Quantitative Determination of 3-Aminopropylsilane on the Surface of FE3O4 Nanoparticles by Attenuated Total Reflection Infrared Spectroscopy
  50. Synthesis of derivatives of the RGD peptide with the residues of glutaric and adipic acids
  51. Functionalization of Fe3O4 magnetic nanoparticles with RGD peptide derivatives
  52. Novel synthetic routes to N-(2-amino-9H-purin-6-yl)-substituted amino acids
  53. The use of 3-mercaptopropyltrimethoxysilane for stabilization of luminescent cadmium sulfide nanoparticles
  54. Covalent Surface Modification of Fe3O4 Magnetic Nanoparticles with Alkoxy Silanes and Amino Acids
  55. Surface modification of Fe3O4 magnetic nanoparticles with (S)-naproxen
  56. Synthesis of novel carboranyl derivatives of α-amino acids
  57. Determination of enantiomeric purity of 1-substituted 3-amino-1,2-dicarba-closo-dodecaboranes by HPLC on chiral stationary phases
  58. Synthesis of N-[(3-Amino-1,2-dicarba-closo-dodecaboran-1-yl)acetyl] Derivatives of α-Amino Acids
  59. Acidic hydrolysis of N-acyl-1-substituted 3-amino-1,2-dicarba-closo-dodecaboranes
  60. Study of the effect of the nature of the side chain in esters of  -amino acids on the diastereoselectivity of condensation with 5(4H)-oxazolone in the synthesis of dipeptides with N-terminal N-acetylphenylalanine
  61. Kinetic resolution of 1-methyl- and 1-phenyl-3-amino-1,2-dicarba-closo-dodecaboranes via acylation with chiral acyl chlorides
  62. Efficient large (ca. 40 g) laboratory scale preparation of (S)- and (R)-valine tert-butyl esters